Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-25T04:09:34.781Z Has data issue: false hasContentIssue false
  • English
  • Français

Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome

Published online by Cambridge University Press:  16 April 2020

Yi-Hsiung Lin ,
Chia-Yih Liu  and
Mei-Chun Hsiao
Yi-Hsiung Lin
Affiliation:
Department of Psychiatry, Chang Gung Medical Center, Tao-Yuan, Taiwan
Chia-Yih Liu
Affiliation:
Department of Psychiatry, Chang Gung Medical Center, Tao-Yuan, Taiwan Department of Psychiatry, Chang Gung University School of Medicine, Tao-Yuan, Taiwan
Mei-Chun Hsiao*
Affiliation:
Department of Psychiatry, Chang Gung Medical Center, Tao-Yuan, Taiwan Department of Psychiatry, Chang Gung University School of Medicine, Tao-Yuan, Taiwan
*
*Corresponding author. Department of Psychiatry, Chang Gung Memorial Hospital (CGMH), 5, Fu-Shin Road, Kuei-San, Tao-yuan 333, Taiwan. E-mail address: norase@adm.cgmh.org.tw (M.-C. Hsiao).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case report
Information
European Psychiatry , Volume 20 , Issue 1 , January 2005 , pp. 76 - 77
Copyright
Copyright © Elsevier SAS 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Archer, JSMRelationship between estrogen, serotonin, and depression. Menopaus 1999;6:71–78.CrossRefGoogle ScholarPubMed
Guidozzi, FEstrogen replacement therapy in breast cancer survivors. Int J Gynecol Obstet 1999;64:59–63.CrossRefGoogle ScholarPubMed
Hadine, J, Lee, SCEstrogen, serotonin, and mood disturbance: where is the therapeutic bridge. Biol Psychiatr 1998;44:798–811.Google Scholar
Loprinzi, CL, Kugler, JW, Sloan, JA, Mailliard, JA, LaVasseur, BI, Barton, DLet al.Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lance 2000;356(9247):2059–2063.CrossRefGoogle ScholarPubMed
North American Menopause Society Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopaus 2003;10(2):113–132.CrossRefGoogle Scholar
Poniatowski, BC, Grimm, P, Cohen, GChemotherapy-induced menopause: a literature review. Cancer Inves 2001;19:641–648.CrossRefGoogle ScholarPubMed
Porter, M, Penney, GC, Russell, D, Russell, E, Templeton, AA population based survey of women’s experience of the menopause. Br J Obstet Gynaecol 1996;313:1025–1028.CrossRefGoogle Scholar
Saarto, T, Blomqvist, C, Valimaki, M, Makela, P, Sarna, S, Elomaa, IChemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 1997;15(4):1341–1347.CrossRefGoogle ScholarPubMed
Weitzner, MA, Moncello, J, Jacobsen, PB, Minton, SA pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manag 2002;23(4):337–345.CrossRefGoogle ScholarPubMed
Zweifel, JE, O’Brien, WHA meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinolog 1997;22(3):189–212.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.